Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis

IMPORTANCE: Intracranial metastatic disease (IMD) is a serious and life-altering complication for many patients with cancer. Targeted therapy may address the limitations of current treatments as an additional agent to achieve intracranial disease control in some patients with IMD. Given the paucity...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Anders W., Brastianos, Priscilla K., Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097701/
https://www.ncbi.nlm.nih.gov/pubmed/32211870
http://dx.doi.org/10.1001/jamanetworkopen.2020.1617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097701/
https://www.ncbi.nlm.nih.gov/pubmed/32211870
http://dx.doi.org/10.1001/jamanetworkopen.2020.1617

Ejemplares similares